Quest Diagnostics India Private Limited - Due diligence report

A 360° intelligence report on Quest Diagnostics India: trust score, financial health, credit view, compliance, directors, growth and distres…

2006-09-14 Basai Road, Haryana Active Unlisted Active Compliant
Share
QD Quest Diagnostics India Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Quest Diagnostics India — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Quest Diagnostics India is assessed as Low Risk with a Trust Score of 82/100. Quest Diagnostics India is an active private limited indian non-government company incorporated in 2006, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Quest Diagnostics India Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
BRIAN FRANCIS LAPENNA 01234567 Director 01/04/2018 6 yrs Approved
GOUTHAM VALLURU 01234567 Director 01/04/2018 6 yrs Approved
SANDIP R PATEL 01234567 Director 01/04/2018 6 yrs Approved
SAKSHI VISHNOI 01234567 Director 01/04/2018 6 yrs Approved
Sean D Mersten 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Quest Diagnostics Incorporated
Subsidiaries
-
Group entities
-
Capital events
36 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Quest Diagnostics Incorporated Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 75
Growth signals & trust indicators
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
25 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
26 Sep 2024
Director appointed
Sean D Mersten (Director)
29 Sep 2022
Director ceased
JING KAI SYZ
31 Jul 2022
Director ceased
WILLIAM JOSEPH OSHAUGHNESSY
14 Nov 2019
Director ceased
BRIAN FRANCIS LAPENNA
Director ceased
GOUTHAM VALLURU
Director ceased
SANDIP R PATEL
11 Mar 2019
Director appointed
SANDIP R PATEL (Director)
Director appointed
SAKSHI VISHNOI (Company Secretary)
04 Jan 2019
Director ceased
DEVIPRASAD RADHAKRISHNAN KARUPPUR
03 Jan 2019
Director appointed
BRIAN FRANCIS LAPENNA (Director)
Director appointed
GOUTHAM VALLURU (Director)
09 Nov 2018
Securities allotted
7150000 Equity Shares Without Differential Rights - 7.15 cr raised
16 Oct 2018
Securities allotted
7150000 Equity Shares Without Differential Rights - 7.15 cr raised
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 36 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Advance Radiodiagnostic Center Private Limited U85100MH2005PTC155669 Akola, Maharashtra, India
P. P. Diagnostics Private Limited U85100PN2008PTC132038 Pune, Maharashtra, India
Akriveia Laboratories Private Limited U85320TG2018PTC124547 Hyderabad, Telangana, India
Jananii Hospital Private Limited U74999TG2016PTC102610 Hyderabad, Telangana, India
Quality Scans Centre Private Limited U85190TZ2013PTC019687 Erode, Tamil Nadu, India
Igenerix Pharma Private Limited U73200UP2008PTC170816 Noida, Uttar Pradesh, India
Neurochem Laboratories Private Limited U24233UP2012PTC053677 Lucknow, Uttar Pradesh, India
Advind Healthcare India Private Limited U29190UP2018PTC107241 Noida, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Quest Diagnostics India before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Quest Diagnostics India: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Quest Diagnostics India - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Quest Diagnostics India pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Quest Diagnostics India - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Quest Diagnostics India an active company?

Quest Diagnostics India has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Quest Diagnostics India financially healthy?

Quest Diagnostics India has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Quest Diagnostics India?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Quest Diagnostics India?

The ultimate holding entity is Quest Diagnostics Incorporated. 5 active director(s) are on record.

Does Quest Diagnostics India have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Quest Diagnostics India up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Quest Diagnostics India?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.